Diabetes Education News

Type 2 diabetes has emerged as a possible risk factor contributing to the development of dementia, but one class of agents used to treat the disease may provide greater protective effects, study results published in BMJ showed.

Once-weekly insulin efsitora alfa provided similar reductions in HbA1c as once-daily insulin degludec among insulin-naive adults with type 2 diabetes and adults with type 1 diabetes previously receiving a basal and bolus insulin analog.

The FDA has granted 510(k) clearance for an insulin patch pump for adults with type 1 or type 2 diabetes, Embecta Corp. announced.

With new guidance now available on monitoring people with early-stage type 1 diabetes, it is crucial for providers to encourage people at high risk to get tested, according to a presenter.

Pregnant women with diabetes can use automated insulin delivery systems with settings optimized to achieve tight glycemic targets, according to two speakers at the Association of Diabetes Care and Education Specialists annual meeting.

A novel once-weekly basal insulin conferred noninferior HbA1c reductions compared with daily insulins for insulin-naive adults with type 2 diabetes and those who switched from daily injections, according to topline results from two trials.

Results from two studies found no association between the use of GLP-1 receptor agonists and increased risk for suicide, suicidal thoughts or depression, findings published in JAMA Internal Medicine showed.

More than one-third of older adults with diabetes lack the digital tools necessary for virtual diabetes self-management education, and providers can play a role in promoting digital inclusion, according to a speaker.

Semaglutide cut the risk for worsening heart failure and CV death for adults with HF with preserved ejection fraction, according to data presented at the European Society of Cardiology Congress and simultaneously published in The Lancet.

Both HbA1c and continuous glucose monitoring metrics have limitations, and providers should not rely on a single metric for managing a patient’s diabetes, according to two speakers.